StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2013 it was 76.3%, against -35.8% the year before. The highest annual figure on record is 76.3% in fiscal 2013.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 201376.3%+112.1
FY2012Dec 31, 2012-35.8%−5.2
FY2011Dec 31, 2011-30.6%+50.9
FY2010Dec 31, 2010-81.5%−48.7
FY2009Dec 31, 2009-32.8%–

More Filana Therapeutics figures

See a number that looks wrong?